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Abstract
Objective—Bone morphogenetic proteins (BMPs) are potently proangiogenic, however the
mechanisms underlying the regulation of vessel development by BMPs are not fully understood.
To assess the significance of BMP endothelial cell precursor-derived regulator (BMPER) in blood
vessel formation in vivo we investigated its role in retinal angiogenesis.
Methods and Results—In a model of oxygen-induced retinopathy, Bmper mRNA expression
and protein levels are downregulated, correlating with the initiation of SMAD phosphorylation in
endothelial cells. Moreover, Bmper haploinsufficiency results in an increased rate of retinal
revascularization, with retinas from Bmper +/− mice displaying increased numbers of branching
points and angiogenic sprouts at the leading edge of the newly formed vasculature. Furthermore,
although Bmper haploinsufficiency does not alter Bmps expression, it does lead to an increase in
BMP signaling, as evidenced by increased pSMAD levels in endothelial cells and increased
expression of known BMP target genes.
Conclusions—These observations provide compelling evidence that BMPER is important in the
regulation of BMP signaling and revascularization in the hypoxic retina. These bring forth the
possibility of novel therapeutic approaches for pathological angiogenesis based on manipulation of
BMP signaling.
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Angiogenesis is the process by which new blood vessels are formed from pre-existing
vascular networks. Although it is a more active process during development than in adult
life, angiogenesis can be reactivated in situations such as wound healing or tumor growth.1
Several factors (e.g. vascular endothelial growth factor (VEGF)2 and angiopoietins3) have
been identified as major regulators of the angiogenic process. However, many more
signaling pathways (such as Notch4 and Wnt5) are now emerging as critical coordinators of
the myriad of events required for proper blood vessel generation6.
Bone morphogenetic proteins (BMPs) belong to the tumor growth factor-β (TGFβ)
superfamily of extracellular signaling proteins. BMPs were initially described by their
ability to induce ectopic bone and cartilage formation,7 however recent evidence reveals an
important role for BMPs in the development of blood vessels during embryonic
development and adult life.8, 9 The relevance of BMPs in angiogenesis is illustrated by the
association of mutations of BMP receptors and SMADs with several human vascular genetic
diseases, such as hemorrhagic hereditary telangiectasia (linked to mutations in ENG,
ACTVRL1, SMAD4), pulmonary artery hypertension (BMPR2, ACTVRL1, SMAD8), and
preeclampsia (levels of soluble endoglin).1 Whereas TGFβs are secreted in a latent or
inactive form, BMPs are secreted as active molecules, with their bioavailability regulated at
the extracellular level through reversible interactions with extracellular regulators.10 One
such protein is BMP endothelial cell precursor-derived regulator or BMPER, the vertebrate
homolog of Drosophila Crossveinless-2 (CV2). BMPER, originally identified in a screen for
differentially-expressed proteins in embryonic endothelial precursor cells 11, is an
extracellular regulator of BMPs required for proper BMP signaling.12–14 Interestingly,
BMPER has been ascribed both pro- and anti-BMP signaling effects in different
experimental settings.11, 12, 15–18 Although the mechanism behind this dual action is still
uncertain, growing evidence indicates that the concentration of BMPER relative to BMP
may determine the nature of its effect on signaling. Initial evidence of this concentration-
dependent action came from studies examining Drosophila posterior crossvein (PCV)
formation. BMPER/CV2 is required for PCV formation and moderately increasing
expression of a BMPER transgene, while BMP remains unaltered, results in a slight gain in
signaling with occasional formation of additional veins. However, continuing to increase
expression levels eventually blocks PCV formation, similar to the effect of knocking out
BMPER in this system.19 We have observed similar dose-dependent effects of BMPER in
several angiogenic assay systems.20 where the addition of BMPER at low concentrations
enhances sprouting and vasculature formation, whereas at high concentrations BMPER
inhibits these processes. In addition, silencing endogenous BMPER or BMP-4 inhibits
HUVEC cell sprouting and migration, indicating that the individual pro-angiogenic function
of each of these proteins in these assays is dependent on the other protein also being
present.20
Recently, we demonstrated that the ratio of BMP4 to BMPER modifies the intracellular
response to BMP-4 in cultured endothelial cells.13 In this instance, low BMPER:BMP-4
ratios led to an increase in signaling evidenced by p-SMAD1/5/8 levels, whereas excess
BMPER inhibits BMP4-mediated phosphorylation of SMADS. Here we extend those
findings to the in vivo setting by describing the functional significance of BMPER in the
regulation of angiogenesis using the oxygen-induced retinopathy (OIR) mouse model.21 The
mouse retina is a well-characterized, readily accessible tissue in which to research
angiogenesis, both from a developmental and a pathological standpoint. Using this model,
we have discovered that BMPER expression is downregulated in vivo in response to sudden
hypoxia, correlating with the initiation of BMP signaling in endothelial cells and the
commencement of revascularization of the retina. These events occur even though Bmp4
levels do not change during the course of hypoxia. Furthermore, Bmper haploinsufficiency
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results in increased SMAD phosphorylation and faster revascularization of the retina,
highlighting the importance of BMPER levels in regulating BMP mediated angiogenesis.
METHODS
A more detailed version of these Methods can be found in the Supplemental Data.
Animals
Bmper+/− mice were generated and maintained as described previously.13 All experimental
procedures on mice were performed according to the National Institutes of Health Guide for
the Care and Use of Laboratory Animals and approved by the Institutional Committee for
the Use of Animals in Research.
Immunostaining
Enucleated eyes were fixed overnight in 4% PFA and dissected whole mounted retinas or
frozen sections were stained appropriately.
RNA Isolation and quantitative reverse transcriptase-polymerase chain reaction (RT-PCR)
RNA was extracted using the RNeasy kit (QIAGEN) and retrotranscribed using the iScript
cDNA Synthesis Kit (Bio-Rad). PCR was performed on an ABI 7900HT Sequence
Detection System (Applied biosystems). Fold change expression was calculated using the
ΔΔCt method using 18S as the internal control.
Statistical analysis
Results are presented as mean ± standard error of the mean (SEM). Comparisons between
groups were made by 2-tailed Student’s t test, one-way or two-way ANOVA to determine
statistical significance between groups.
RESULTS
Hypoxia downregulates BMPER expression in endothelial cells
Since both hypoxia and BMP signaling are linked to angiogenesis, we postulated that
hypoxic conditions could affect the expression of BMPs and BMPER in endothelial cells. In
order to test this theory, we first examined the regulation of Bmp4 and Bmper mRNA levels
in various endothelial cells cultured under hypoxic (1% oxygen) or normoxic (21% oxygen)
conditions for 24 hours. We chose to focus on Bmp4 as our previous studies demonstrated
that BMPER can regulate BMP4-mediated angiogenesis in endothelial cells20. Under these
conditions, Bmper levels were significantly downregulated in response to hypoxia in MEC
(mouse myocardial endothelial cells), C166 (mouse embryonic yolk sac endothelial cells)
and MS1 (mouse pancreas microvascular endothelial cells; Figure 1A). In contrast, little to
no change in Bmp4 levels were seen in C166 and MS1 cells under hypoxic conditions,
whereas hypoxic MECs exhibited a 42% increase in Bmp4 levels compared to the same cells
cultured under normoxic conditions (Figure 1A). ELISA analysis confirmed that, while
BMP4 protein was not affected, BMPER protein levels were significantly reduced in both
the cell lysate (Figure 1B) and extracellular media (Figure 1C) of both MEC and C166 cells
under hypoxic conditons.
BMPER expression is downregulated in vivo in the mouse retina during OIR
To study the role of BMPER in the regulation of angiogenesis in vivo, we turned to the
retina since it provides an easily accessible system in which to study vessel development and
because we had identified this tissue as an enriched location of Bmper transcript levels
Moreno-Miralles et al. Page 3













(Supplemental Figure I). We examined whether BMPER could modulate angiogenesis under
hypoxia-induced re-vascularization using the OIR model. Using this model, we observed
that Bmper levels decreased approximately two fold soon after the onset of hypoxia (P14
and subsequent time points) when compared to the level of retinal Bmper at P12 and P13
(Figure 1D). This difference was confirmed by ANOVA analysis and post-test for linear
trend. BMPER protein levels were also reduced in whole retina extracts at P14 (Figure 1E).
Next the regulation of Bmp4 during this period of hypoxic-revascularization of the retina
was examined. Bmp4 transcript levels decreased briefly at P14 (not statistically significant
as determined by ANOVA analysis) but then returned to normal levels by P15 and
subsequent time points (Figure 1D). Analysis of BMP4 protein levels at P12 and P14 in
independent samples demonstrated a slight (but not statistically significant) increase in
expression (Figure 1F). In addition, mRNA levels of other Bmps analyzed showed no
significant changes during retinal revascularization (Supplemental Figure 2). These findings
indicate that exposure of retinal tissue to hypoxia in vivo induces downregulation of Bmper
levels without significantly affecting Bmps expression, similar to our observations from in
vitro experiments with endothelial cells.
BMPER downregulation correlates with the initiation of BMP signaling in hypoxic retinas
Our previous observations that reduced concentrations of BMPER correlate with an increase
in BMP activity13 raised the possibility that the decrease in BMPER levels seen in the
hypoxic retinas following OIR might correlate with an increase in endogenous BMP
signaling within the retina. To test this theory, we examined the levels of phosphorylated
SMADS 1/5/8 in retinas before (P12) and after (P14) the onset of hypoxia. Whereas no
SMAD phosphorylation could be detected at P12, strong phospho-SMAD1/5/8 was detected
at P14 in nuclei from both endothelial cells (iso-lectin positive) and astrocytes (round nuclei
in close proximity to endothelial cells, Figure 2A), even though Bmp4 expression itself was
not increased at this time point (Figure 1D). Since BMPs can also signal via ERK1/2 in
endothelial cells,22 we next examined whether ERK1/2 stimulation was also affected in
response to hypoxic stimulation in the retinas. Western blot analysis of retina lysates
revealed that ERK1/2 was also strongly phosphorylated in response to hypoxia (P14; Figure
2B). Immunofluorescence staining of frozen sections from P12 and P14 retinas confirmed
that the location of the pERK1/2 signal was indeed endothelial cells and some closely
adjacent iso-lectin negative cells, most likely pericytes. No pERK1/2 staining was detected
in astrocytes (Figure 2C). Our data imply that, in the hypoxic retina, BMP signaling within
the endothelium is controlled through Bmper regulation rather than through changes in
Bmp4 expression.
Bmper haploinsuficiency accelerates retinal revascularization in OIR
To further understand the physiological role of BMPER in the development of retinal
vasculature, we measured the pattern and rate of blood vessel formation in genetically
modified mice. Because Bmper-/- animals die at birth,13 we examined the differences
between WT and Bmper+/− mice. Following five days of hyperoxia (i.e., P12), Bmper+/−
animals exhibited a similar degree of retinal avascularity as compared with WT littermate
controls (Figure 3A, B). However, once hypoxia was established, Bmper haploinsufficiency
correlated with a faster recovery of the retinal vascular bed as indicated by a reduced
percentage of avascularized area in the retinas of the Bmper+/− mice at later time points. At
two (P14) and four (P16) days following the onset of hypoxia, Bmper+/− mice displayed
25% and 30% more retinal vascularization than the respective WT littermate controls
(Figure 3A, B), with no differences in intravitreous neovascularization, an indication of
pathological aberrant angiogenesis (Figure 3C). The increase in intraretinal vascularization
seen in the Bmper+/− mice following the onset of hypoxia was accompanied by a more
dense and complex network of newly formed vessels. The leading edge of the newly formed
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vasculature in Bmper+/− mice revealed approximately 20% more vascularization compared
with the littermate controls (Figure 3D and E) with an increase in the number of connections
between the new vessels (Figure 3G) and increased numbers of sprouts compared to WT
littermates (Figure 3H). (Online supplement). Together, these observations reveal a role for
low concentrations of BMPER in the angiogenic response of endothelial cells from hypoxic
retinas, which is consistent with our previous in vitro data13.
New vessel formation in Bmper +/− retinas follows astrocytic scaffolding and recruits
pericytes in a normal fashion
One important aspect of vascular development in the retina is the interaction of endothelial
cells with the pre-existing scaffolding laid down by the astrocytic network.23 To determine
whether the changes observed in the retinal vasculature of Bmper +/− mice are related to
alterations in guidance cues provided by other cells, we examined the relationship between
these newly formed vessels and the resident astrocytic network in both Bmper +/− and WT
mice. Immunostaining of retinas at two days following the onset of hypoxia (P14) with iso-
lectin (endothelial cells) and GFAP (astrocytes) revealed that the pattern of the astrocytic
network was not significantly different between Bmper +/− and WT animals (Figure 4A).
Closer examination of the filopodia of the endothelial cells at the tip of the growing vascular
sprouts in Bmper +/− mice revealed that these cells followed the astrocytic network
similarly to what was found in WT animals (Figure 4A), indicating a stable interaction
between the endothelial cells and adjacent astrocytes in the Bmper +/− retinas. The proper
formation of a stable vasculature also requires the recruitment of pericytes to the wall of the
new vessels.25 In order to study the presence of pericytes in the neovascularized region of
the retinas we co-stained P14 retinas with iso-lectin and NG2 (pericytes), and discovered
that both WT and Bmper +/− miceBmper+/− retinas displayed appropriate coverage of new
vessels with pericytes, in a ratio of 3:1 (endothelial cell:pericyte; Figure 4B).24 Thus,
although Bmper haploinsufficiency leads to an increased growth rate of retinal vasculature,
this vasculature is both normal in appearance and arranged so as to be fully functional once
completely laid down.
Bmper haploinsuficiency increases BMP signaling in endothelial cells in response to
hypoxia
Given our in vitro findings that lower concentrations of BMPER increase BMP-mediated
SMAD signaling in endothelial cells, we next sought to determine if the mechanism
underlying the accelerated revascularization in the retinas of Bmper+/− mice was also
linked to an increase in BMP signaling. Frozen sections of WT and Bmper+/− retinas taken
at P15 (72 hours in hypoxia) were stained with an anti-pSMAD1/5/8 antibody (Figure 5A)
and the intensity of the nuclear signal in both endothelial cells and astrocytes was quantified.
As expected, retinas from Bmper+/− animals exhibited increased nuclear SMAD signaling
in both endothelial cells and astrocytes (Figure 5B, C).
In an effort to understand the mechanism of this altered BMP regulation in the Bmper+/−
retinas we compared the time course of Bmper mRNA regulation in the retinas following the
onset of hypoxia. We discovered that Bmper downregulation occurred earlier in the Bmper
+/− retinas compared to WT retinas (Figure 6A). Whereas WT controls demonstrated a
reduction in Bmper mRNA at 48 hours following the start of hypoxic treatment (i.e. P14), in
Bmper+/− retinas Bmper mRNA was already decreased after only 24 hours of hypoxia (i.e.
P13), even though at this point in the experiment no differences in vascularization patters
could be detected. In addition, Bmp4, Bmp2, Bmp6 or Bmp7 levels did not demonstrate
significant changes during the course of hypoxia in Bmper+/− retina, similar to what was
seen in WT controls (Figure 6B and Supplemental Figure II). Finally, we confirmed the
altered modulation of BMP signaling in Bmper+/− retinas by investigating the expression of
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BMP target genes in the OIR-treated retinas. As revascularization occurs Bmper+/− retinas
displayed an increase in the expression of the ERK1/2-regulated gene Mmp925 compared to
WT retinas (Figure 6C). MMP9 has been linked to the regulation of angiogenesis in various
contexts6 and specifically in the ordered revascularization of the mouse retina26. In addition,
quantitative RT-PCR of the SMAD regulated gene Msx1 confirmed an increased response to
BMP signaling in Bmper+/− retinas (Figure 6D). Msx1, which is a known BMP target gene
expressed by pericytes and endothelial cells,27, 28 was steadily upregulated during the course
of hypoxia in WT retinas, which was in contrast to Bmper+/− retinas which exhibited an
accelerated increase in Msx1 levels following the onset of hypoxia (Figure 6D).
DISCUSSION
The role that BMPs play in the processes of angiogenesis and vasculogenesis is widely
accepted. Still, despite the progress made in recent years, the mechanisms of BMP-mediated
vessel formation are not fully understood.8, 9 The BMP signaling pathway comprises a
complex network of extracellular, membrane and intracellular regulators29. Recently we
discovered two new BMP-regulated genes, Cox2 and MyoX,30, 31 that mediate the
downstream angiogenic properties of BMP. In the current study, we turned our focus to
regulatory elements upstream of BMP in the angiogenesis signaling cascade and
investigated the role that BMPER, an extracellular modulator of BMP signaling, plays in the
regulation of BMP-mediated angiogenesis in vivo. Previously, we have shown BMPER to
modify the angiogenic response of endothelial cells to BMPs in in vitro experiments.13, 20 In
addition, BMPER has been implicated, albeit indirectly, in the vascular phenotypes
associated with the FoxO knock-out mouse,32 in a thoracic aortic aneurysm mouse model33
and in hypoplastic left heart syndrome.34 However, until now, no studies have demonstrated
the modulation of endogenous BMBER in response to physiological stimuli, nor has
BMPER been shown to be able to regulate angiogenic processes in vivo. Our data provide
the first evidence that endogenous BMPER levels are regulated in response to hypoxia both
in endothelial cells in vitro and in vivo and that this regulation of BMPER levels has a direct
effect on angiogenic processes in a mouse model of OIR.
Previously we had demonstrated that BMPER regulates BMP4 action in vitro via a
concentration-dependent mechanism, switching from a pro- to an anti-BMP effector,
depending on the concentration of exogenously added BMPER.13, 20 Until now, however,
the physiological significance of this concentration-dependent relationship between BMPER
and BMP was not known. Using endothelial cell cultures and a mouse model of OIR to
induce revascularization in the retina, we discovered that hypoxia and the start of retinal
revascularization coincides with a physiological down-regulation of BMPER and a
concurrent increase in BMP signaling in retinal endothelial cells and astrocytes (Figures 1
and 2). Interestingly, however, measurement of the in vivo levels of Bmps in retinas from
mice exposed to the OIR model demonstrated no change in Bmps expression (Figure 1 and
Supplemental Figure II). If our hypothesis that lower BMPER:BMP concentration ratios
drives BMPER’s pro-BMP effects is correct, our results here suggest that the endogenous
level of BMPER in the revascularizing retina is decreased such that it is lower than the local
concentration of BMPs. Indeed, Bmper+/− retinas (in which Bmper expression is decreased
by approximately 50% compared to WT retinas; Supplemental Figure III), exhibit enhanced
physiologic BMP signaling in vivo, evidenced by an increase in SMAD phosphorylation
(Figure 5) and BMP target gene expression in retinal lysates (Figure 6). These findings
underscore the role of extracellular regulators such as BMPER in modulating BMP signaling
at the protein level and not through enhanced transcriptional regulation of BMPs after
angiogenic stimuli.
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Despite demonstrating that Bmper haploinsufficiency correlates with increased BMP
signaling and increased angiogenesis (Figures 3, 5 and 6), we were surprised to discover that
the retinas of Bmper+/− mice were anatomically indistinguishable from the retinas of their
WT siblings in terms of basal vascular development (P6 and P12; Supplemental Figure III).
Given our previous observations, we would have predicted that the hypoxic interludes that
occur throughout retinal vasculature development, teamed with the already decreased level
of Bmper expression would lead to a heightened degree of BMP activation in the Bmper+/−
retinas and result in an increase in vascularization. One possible explanation for the lack of
increased angiogenesis in the Bmper+/− retinas during development could be that signaling
through other pathways (such as VEGF) could be sufficient to drive retina vascularization
during normal development but not in a stress-induced situation such as the OIR model. This
could be explained by the nature of the hypoxia induced in the OIR model compared to the
hypoxia experienced naturally during development. The developing retina, although still
hypoxic in comparison to the mature retina does have a balance between oxygen supply
(hyaloid vessels regress around P7) and demand (immature neural retina), whereas the
obliterated zone of the retina in mice exposed to the OIR model suffers a sudden oxygen
undersupply.35, 36 In fact, the OIR mouse model recapitulates many of the hallmarks of
retinopathy of prematurity in humans,37 and thus BMPER-mediated effects on BMP-
induced angiogenesis may have more relevance to angiogenesis that is re-activated in
pathologic conditions where sudden hypoxia drives neovascularization, such as wound
healing, cardiovascular disorders or tumor growth.1 This is not to say that BMPER is
irrelevant during developmental processes. During embryonic development, Bmper is
expressed in the ribs, skull, long bones and limb girdle bones during the period of bone
maturation. Consistent with this pattern of expression, Bmper knock-out animals have a
variety of bone defects characterized by reduced ossification.12, 14 Invasion by endothelial
cells and vascularization of the ossification centers is a critical step in bone maturation.38
Therefore, given our observations of BMPER’s role in angiogenesis in the retina, it is
possible that the bone phenotype of Bmper null animals could be attributed, in part, to a
defect in proper vascular invasion of the cartilage template.
Organized vascularization, both through stimulation of angiogenesis and remodeling of
existing vasculature, is essential not only for physiologic development of the retina but also
for the normal development of most other tissues. The developing mouse retina is an
excellent canvas in which to study the induction of vascularization and revascularization, the
findings of which can apply equally to developmental angiogenesis and pathological
conditions. In spite of the progress made in recent years, the full mechanisms by which
BMPs induce vascular development still remain relatively unknown, especially in terms of
the regulators that monitor and determine the outcome of BMP-signaling. Our observations
in hypoxia-driven revascularization of the retina offer an insight into the physiological
regulation of BMP signaling by BMPER. Our data offers an exciting revelation of BMPER-
mediated regulation of BMP signaling that could end up being a potential target for
therapeutic intervention in pathological conditions involving aberrant angiogenesis.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. BMPER expression is downregulated in endothelial cells in response to hypoxia
A-C, MEC, MS1 and C166 cells were cultured for 24 hours in normoxic (open bars) or
hypoxic (closed bars) conditions. Fold change in mRNA expression (A) or protein levels of
BMP4 and BMPER from cell lysates (B) or extracellular media (C) is represented relative to
corresponding levels under normoxic conditions. D-F, Wild type mice were subjected to
OIR and BMPER and BMP4 mRNA (D) and protein (E, F) expression was determined from
the retina of different animals at each time point. The change in expression at each time
point is represented relative to the levels measured at P12 (0 days in hypoxia) (n= 3 to 4). *
p,0.05, ** p<0.01, *** p<0.001, n.s. not significant.
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Figure 2. Hypoxia-induced retinal revascularization is accompanied by SMAD1/5/8 and ERK1/2
phosphorylation in endothelial cells
Retinal sections from OIR-subjected mice at P12 (0 days hypoxia) and P14 (2 days hypoxia)
were stained with fluorescently-labeled iso-lectin (red), anti-pSMAD1/5/8 (green in A) or
anti-pERK1/2 (green in C), and DAPI (blue) or total lysates were probed by western blot
analysis with antibodies to pERK1/2 and total ERK1/2. INL: inner nuclear layer, IPL: inner
plexiform layer, SVP: superficial vascular plexus, V: vitreous. *** p<0.001. Scale bars:
20μm.
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Figure 3. Bmper+/− retinas display increased intraretinal re-vascularization during the course of
hypoxia
A, Iso-lectin-stained retinal whole mounts from WT and Bmper+/− mice at different time
points during hypoxia-induced revascularization. B-C, Avascularized (white outline) (B) and
intravitreous neovascularization (IVNV) (C) areas were quantified from whole-mounted
retinas (n= 3 to 8 mice per time point and genotype). D, Confocal micrographs of retinal flat
mounts stained with iso-lectin from P14 WT or Bmper+/− OIR mice. E-H, Vascularized
area (E), branching points (asterisks) (G) and vessels sprouts (arrows) (H) were quantified
within the leading edge of re-vascularization area (white outline) in at least 5 random fields
of view per retina (n= 3 mice per genotype). WT (open bars), Bmper+/− (closed bars). * p,
0.05, ** p<0.005. Scale bars: 500 μm (A) and 50 μm (D).
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Figure 4. Angiogenesis in Bmper+/− mice indicates normal astrocyte-filopodia interactions and
pericyte recruitment
Flat mounted whole retinas from P14 WT or Bmper+/− mice subjected to OIR were co-
stained with iso-lectin (red), DAPI (blue) and GFAP (A) or NG2 (B) (green) and z-stacked
images were acquired on a confocal microscope. For endothelial cell:pericyte ratio
calculations, nuclei from pericytes (green) and endothelial cells (red) were quantified. Scale
bars: 20 μm.
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Figure 5. BMP signaling increases in in retinal endothelial cells and astrocytes from OIR-treated
Bmper+/− mice
A, Retinal sections from P15 (3 days hypoxia) WT and Bmper+/− mice were stained with
iso-lectin (red), anti-pSMAD1/5/8 (green) and DAPI (blue). B-C, The intensity of nuclear
pSMAD1/5/8 signal was quantified in endothelial cells (iso-lectin positive) (B) and
astrocytes (C) using ImageJ software. Nuclear mean intensity was measured from at least 10
random fields in sections 70μm apart from two mice per genotype group. INL: inner nuclear
layer, IPL: inner plexiform layer, SVP: superficial vascular plexus, V: vitreous. ***
p<0.001. Scale bar: 11 μm.
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Figure 6. Bmper haploinsufficieny leads to enhanced expression of BMP and ERK target genes
Mice were subjected to OIR and RNA extracted from the retina of WT (open bars) or Bmper
+/− (closed bars) littermate animals. Bmper (A), Bmp4 (B), Mmp9 (C) and Msx1 (D) mRNA
expression at each time point was determined by quantitative RT-PCR. For comparison
purposes the relative expression of Bmper and Bmp4 in WT animals from Figure 1 is
reproduced here. Expression at every time point is represented relative to the corresponding
P12 expression (0 days hypoxia) for each genotype group (n= 3 to 4 mice per genotype) in
B-E. * p,0.05, ** p<0.01, *** p<0.001.
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